Advertisement

Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy

      Refractory progressive heart failure (HF) is becoming the predominant cause of mortality in nonobstructive hypertrophic cardiomyopathy (HC). To anticipate development of this important and often unpredictable clinical course, we investigated whether left ventricular diastolic dysfunction, assessed by echocardiographic Doppler parameters, could identify a subset of patients with HC without obstruction at rest who would experience progression of HF. Diastolic function parameters, assessed by Doppler tissue imaging (DTI), mitral inflow, and pulmonary venous flow were measured in 274 consecutive adult patients with HC evaluated from 2003 to 2007. DTI and other diastolic and clinical/demographic parameters were measured against the composite end point of HF/death, heart transplantation, or progression to advanced New York Heart Association functional class III/IV symptoms and sudden death (SD)/implantable defibrillator (ICD) interventions. HF end points were reached in 19 of 274 patients (7%) over a follow-up period of 4.0 ± 2.3 years. Variables significantly associated with HF outcome by univariate analysis included male gender, initial New York Heart Association class II, lower ejection fraction, and reduced septal and lateral e′ mitral annular tissue velocities. Multivariable analysis showed only a reduced lateral e′ mitral annular tissue velocity to be independently associated with the composite HF end points (HR 0.77; 95% CI 0.65 to 0.91; p = 0.003). In addition, estimated pulmonary arterial systolic pressure and extensive late gadolinium enhancement by magnetic resonance were also associated with HF outcome (p = 0.04 and p <0.001, respectively). No Doppler (or clinical) variable was associated with SD/appropriate ICD interventions. In conclusion, in HC without outflow obstruction at rest, diastolic dysfunction, evidenced by DTI-reduced lateral e′ mitral annular tissue velocity, was associated with adverse long-term HF outcome but was unrelated to SD. This echocardiographic marker provides a potential noninvasive strategy for anticipating progressive HF in this HC patient group.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Maron B.J.
        • Rowin E.J.
        • Casey S.A.
        • Link M.S.
        • Lesser J.R.
        • Chan R.H.
        • Garbrich R.F.
        • Udelson J.E.
        • Maron M.S.
        Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies.
        J Am Coll Cardiol. 2015; 65: 1915-1928
        • Maron B.J.
        • Ommen S.R.
        • Semsarian C.
        • Spirito P.
        • Olivotto I.
        • Maron M.S.
        Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
        J Am Coll Cardiol. 2014; 64: 83-99
        • Elliott P.M.
        • Anastasakis A.
        • Borger M.A.
        • Borggrefe M.
        • Cecchi F.
        • Charron P.
        • Hagege A.A.
        • Lafont A.
        • Limongelli G.
        • Mahrholdt H.
        • McKenna W.J.
        • Mogensen J.
        • Nihoyannopoulos P.
        • Nistri S.
        • Pieper P.G.
        • Pieske B.
        • Rapezzi C.
        • Rutten F.H.
        • Tillmanns C.
        • Watkins H.
        2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
        Eur Heart J. 2014; 35: 2733-2779
        • Melacini P.
        • Basso C.
        • Angelini A.
        • Calore C.
        • Bobbo F.
        • Tokajuk B.
        • Bellini N.
        • Smaniotto G.
        • Zucchetto M.
        • Illiceto S.
        • Thiene G.
        • Maron B.J.
        Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.
        Eur Heart J. 2010; 31: 2111-2123
        • Autore C.
        • Bernabò P.
        • Barillà C.S.
        • Bruzzi P.
        • Spirito P.
        The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.
        J Am Coll Cardiol. 2005; 45: 1076-1080
        • Maron M.S.
        • Olivotto I.
        • Zenovich A.G.
        • Link M.S.
        • Pandian N.G.
        • Kuvin J.T.
        • Nistri S.
        • Cecchi F.
        • Udelson J.E.
        • Maron B.J.
        Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
        Circulation. 2006; 114: 2232-2239
        • Ommen S.R.
        • Maron B.J.
        • Olivotto I.
        • Maron M.S.
        • Cecchi F.
        • Betocchi S.
        • Gersh B.J.
        • Ackerman M.J.
        • McCully R.B.
        • Dearani J.A.
        • Schaff H.V.
        • Danielson G.K.
        • Tajik A.J.
        • Nishimura R.A.
        Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2005; 46: 470-476
        • Nagueh S.F.
        • Lakkis N.M.
        • Middleton K.J.
        • Spencer III, W.H.
        • Zoghbi W.A.
        • Quiñones M.A.
        Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy.
        Circulation. 1999; 99: 254-261
        • Maron B.J.
        • Spirito P.
        • Green K.J.
        • Wesley Y.E.
        • Bonow R.O.
        • Arce J.
        Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 1987; 10: 733-742
        • Nagueh S.F.
        • Appleton C.P.
        • Gillebert T.C.
        • Marino P.N.
        • Oh J.K.
        • Smiseth O.A.
        • Waggoner A.D.
        • Flachskampf F.A.
        • Pellikka P.A.
        • Evangelista A.
        Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
        J Am Soc Echocardiogr. 2009; 22: 107-133
        • Nagueh S.F.
        • Bierig S.M.
        • Budoff M.J.
        • Desai M.
        • Dilsizian V.
        • Eidem B.
        • Goldstein S.A.
        • Hung J.
        • Maron M.S.
        • Ommen S.R.
        • Woo A.
        • American Society of Echocardiography
        • American Society of Nuclear Cardiology
        • Society for Cardiovascular Magnetic Resonance
        • Society of Cardiovascular Computed Tomography
        American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy.
        J Am Soc Echocardiogr. 2011; 24: 473-498
        • Biagini E.
        • Spirito P.
        • Rocchi G.
        • Ferlito M.
        • Rosmini S.
        • Lai F.
        • Lorenzini M.
        • Terzi F.
        • Bacchi-Reggiani L.
        • Boriani G.
        • Branzi A.
        • Boni L.
        • Rapezzi C.
        Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy.
        Am J Cardiol. 2009; 104: 1727-1731
        • Chan R.H.
        • Maron B.J.
        • Olivotto I.
        • Pencina M.J.
        • Assenza G.E.
        • Haas T.
        • Lesser J.R.
        • Gruner C.
        • Crean A.M.
        • Rakowski H.
        • Udelson J.E.
        • Rowin E.
        • Lombardi M.
        • Cecchi F.
        • Tomberli B.
        • Spirito P.
        • Formisano F.
        • Biagini E.
        • Rapezzi C.
        • De Cecco C.N.
        • Autore C.
        • Cook E.F.
        • Hong S.N.
        • Gibson C.M.
        • Manning W.J.
        • Applebaum E.
        • Maron M.S.
        Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
        Circulation. 2014; 130: 484-495
        • Maron B.J.
        • Spirito P.
        • shen W.K.
        • Haas T.S.
        • Formisano F.
        • Link M.S.
        • Epstein A.E.
        • Almquist A.K.
        • Daubert J.P.
        • Lawrenz T.
        • Boriani G.
        • Estes III, N.A.
        • Favale S.
        • Piccininno M.
        • Winters S.L.
        • Santini M.
        • Betocchi S.
        • Arribas F.
        • Sherrid M.V.
        • Buja G.
        • Semsarian C.
        • Bruzzi P.
        Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
        JAMA. 2007; 298: 405-412
        • Harris K.M.
        • Spirito P.
        • Maron M.S.
        • Zenovich A.G.
        • Formisano F.
        • Lesser J.R.
        • Mackey-Bojack S.
        • Manning W.J.
        • Udelson J.E.
        • Maron B.J.
        Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.
        Circulation. 2006; 114: 216-225
        • Rowin E.J.
        • Maron B.J.
        • Kiernan M.S.
        • Casey S.A.
        • Feldman D.S.
        • Hryniewicz K.M.
        • chan R.H.
        • Harris K.M.
        • Udelson J.E.
        • DeNofrio D.
        • Roberts W.C.
        • Maron M.S.
        Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant.
        Circ Heart Fail. 2014; 7: 967-975
        • Gersh B.J.
        • Maron B.J.
        • Bonow R.O.
        • Dearani J.A.
        • Fifer M.A.
        • Link M.S.
        • Naidu S.S.
        • Nishimura R.A.
        • Ommen S.R.
        • Rakowski H.
        • Seidman C.E.
        • Towbin J.A.
        • Udelson J.E.
        • Yancy C.W.
        2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
        J Am Coll Cardiol. 2011; 58: e212-260
        • Maron B.J.
        Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
        Circulation. 2010; 121: 445-456
        • Pinamonti B.
        • Merlo M.
        • Nangah R.
        • Korcova R.
        • Di Lenarda A.
        • Barbati G.
        • Sinagra G.
        The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance.
        J Cardiovasc Med (Hagerstown). 2010; 11: 669-677
        • Kitaoka H.
        • Kubo T.
        • Hayashi K.
        • Yamasaki N.
        • Matsumura Y.
        • Furuno T.
        • Doi Y.L.
        Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
        Eur Heart J Cardiovasc Imaging. 2013; 14: 544-549
        • Matsumura Y.
        • Elliott P.M.
        • Virdee M.S.
        • Sorajja P.
        • Doi Y.
        • McKenna W.J.
        Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity.
        Heart. 2002; 87: 247-251
        • Bayrak F.
        • Kahveci G.
        • Mutlu B.
        • Sonmez K.
        • Degertekin M.
        Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy.
        Eur J Echocardiogr. 2008; 9: 278-283
        • Reant P.
        • Reynaud A.
        • Pillois X.
        • Dijos M.
        • Arsac F.
        • Touche C.
        • Landelle M.
        • Rooryck C.
        • Roudaut R.
        • Lafitte S.
        Comparison of resting and exercise echocardiographic parameters as indicators of outcomes in hypertrophic cardiomyopathy.
        J Am Soc Echocardiogr. 2015; 28: 194-203
        • McMahon C.J.
        • Nagueh S.F.
        • Pignatelli R.H.
        • Denfield S.W.
        • Dreyer W.J.
        • Price J.F.
        • Clunie S.
        • Bezold L.I.
        • Hays A.L.
        • Towbin J.A.
        • Eidem B.W.
        Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy.
        Circulation. 2004; 109: 1756-1762
        • Geske J.B.
        • Sorajja P.
        • Nishimura R.A.
        • Ommen S.R.
        Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization.
        Circulation. 2007; 116: 2702-2708
        • Nishimura R.A.
        • Appleton C.P.
        • Redfield M.M.
        • Ilstrup D.M.
        • Holmes Jr., D.R.
        • Tajik A.J.
        Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study.
        J Am Coll Cardiol. 1996; 28: 1226-1233